S5–03–02: NGF processing and Alzheimer's neurodegeneration: Too–little NGF and too–much pro–NGF? | Zendy

Cattaneo Antonino | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

S5–03–02: NGF processing and Alzheimer's neurodegeneration: Too–little NGF and too–much pro–NGF?

Author(s) -

Cattaneo Antonino

Publication year - 2006

Publication title -

alzheimer's and dementia

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.713

H-Index - 118

eISSN - 1552-5279

pISSN - 1552-5260

DOI - 10.1016/j.jalz.2006.05.363

Subject(s) - neurodegeneration , nerve growth factor , basal forebrain , cholinergic neuron , tropomyosin receptor kinase a , low affinity nerve growth factor receptor , nucleus basalis , neuroscience , trk receptor , biology , neurotrophin , cholinergic , medicine , endocrinology , receptor , microbiology and biotechnology , disease

not available. S5-03-06 C. ELEGANS IN MODIFIER GENES Gerald Schellenberg, University of Washington, Seattle, WA, USA. Contact e-mail: Zachdad@u.washington.edu Abstract not available.not available. THURSDAY, JULY 20, 2006 SYMPOSIA S5-04 THERAPEUTICS S5-04-01 PHARMACOLOGICAL TREATMENTS OF PSYCHIATRIC SYMPTOMS IN ALZHEIMER’S DISEASE Pierre N. Tariot, University of Rochester, Rochester, NY, USA. Contact e-mail: pierre_tariot@urmc.rochester.edu Abstract not available.not available. S5-04-02 ARE CHOLINESTERASE INHIBITORS EFFECTIVE TREATMENT FOR AGITATED BEHAVIOUR IN ALZHEIMER’S DISEASE? FIRST RESULTS OF THE CALM-AD TRIAL Robert Howard, Institute of Psychiatry, London, United Kingdom. Contact e-mail: r.howard@iop.kcl.ac.uk Abstract not available. S93 Symposia S5-04: Therapeuticsnot available. S93 Symposia S5-04: Therapeutics

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research